Researcher.Life Logo

European Journal of Haematology : Impact Factor & More

eISSN: 1600-0609pISSN: 0902-4441

Key Metrics

CiteScore
5.2
Impact Factor
< 5
SJR
Q2Hematology
SNIP
1.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European Journal of Haematology

European Journal of Haematology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1987
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in European Journal of Haematology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Journal of Haematology

Title not available
  • 1 Jun 2026
  • European Journal of Haematology
Rate of MGUS Progression to Haematological Malignancies: A Systematic Review.
  • 1 Jun 2026
  • European journal of haematology
Oral Anticoagulation After Atrial Fibrillation Ablation: An Updated Systematic Review and Meta-Analysis of 267 443 Patients.
  • 1 Jun 2026
  • European journal of haematology
Management of Primary Refractory Diffuse Large B-Cell Lymphoma in Patients Unsuitable for CAR T-Cell Therapy.
  • 1 Jun 2026
  • European journal of haematology
Prophylactic Donor Lymphocyte Infusions in Pediatric Patients With High-Risk Hematological Malignancies.
  • 1 Jun 2026
  • European journal of haematology
To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted Therapy.
  • 14 May 2026
  • European journal of haematology
Title not available
  • 1 Jun 2026
  • European Journal of Haematology
Rate of MGUS Progression to Haematological Malignancies: A Systematic Review.
  • 1 Jun 2026
  • European journal of haematology
Oral Anticoagulation After Atrial Fibrillation Ablation: An Updated Systematic Review and Meta-Analysis of 267 443 Patients.
  • 1 Jun 2026
  • European journal of haematology
Management of Primary Refractory Diffuse Large B-Cell Lymphoma in Patients Unsuitable for CAR T-Cell Therapy.
  • 1 Jun 2026
  • European journal of haematology
Prophylactic Donor Lymphocyte Infusions in Pediatric Patients With High-Risk Hematological Malignancies.
  • 1 Jun 2026
  • European journal of haematology
To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted Therapy.
  • 14 May 2026
  • European journal of haematology

FAQs on European Journal of Haematology